A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at at least US$3.3 billion, said two people with direct knowledge of the matter.
Exclusive: Sinopharm-led consortium plans US$3.3 billion take-private of HK-listed China TCM – sources
